TOP-ANK: Efficacy of Nasal Oxygen Therapy to Reduce Postoperative Complications in Ankle Trauma Surgery in At-risk Patients: a Randomized Pilot Study.

Sponsor
Nantes University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05185115
Collaborator
Radiometer Medical ApS (Industry)
200
1
2
28.9
6.9

Study Details

Study Description

Brief Summary

Ankle fractures are one of the most common surgeries in the world. After this kind of surgery, complications can occur, related to the scar or an infection. These complications are more frequent in "high-risk" patients. Nasal oxygen therapy is currently used in order to reduce these complications. However, no study proved its efficiency yet. In a cohort of 200 patients, one group will receive oxygen therapy during hospitalization, while the other will not. Complication rates will be observed up to 6 months after the operation

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

Prospective, single-center, comparative and randomized study based on a cohort of 200 patients with an ankle fracture. The patients will be assigned to one of the following group: with or without oxygen therapy. Patients in the experimental group will receive the oxygen just before the operation, and during the hospitalization. The rest of the care is the same for the 2 groups. Comparison of complication rate, of quality of healing, rate of revision surgery, delay in bone healing, rate of pseudoarthrosis, and ankle pain will be done between the 2 groups during a postoperative period of 6 months. A cost-utility analysis will also be realized. In a subgroup of 40 patients, additional transcutaneous oxygen pressure measurements will be performed to compare the evolution of tissue oxygenation between the 2 groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Efficacy of Nasal Oxygen Therapy to Reduce Postoperative Complications in Ankle Trauma Surgery in At-risk Patients: a Randomized Pilot Study
Anticipated Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group (A)

Patients treated with 3 liters per minute oxygen delivered via nasal cannula duration hospitalization

Drug: Oxygen
administration of oxygen at a flow rate of 3 liters per minute, via nasal cannula throughout the hospitalization.
Other Names:
  • O2
  • Other: Control group (B)

    No oxygen therapy during hospitalization

    Other: no oxygen therapy
    No oxygen therapy during hospitalization

    Outcome Measures

    Primary Outcome Measures

    1. Cutaneous and infectious complications [6 months]

      Post-surgery ankle complications including skin damage (ecchymosis, phlyctena), necrosis, superficial and deep infection and scar disunion

    Secondary Outcome Measures

    1. Observer Scar Assessment Scale (OSAS questionnaire) [3 weeks after surgery]

      The OSAS grid is used to evaluate the tolerance and scar quality obtained by the operator. It is based on an evaluation of the healing process thanks to 7 questions whose answers are rated according to an increasing scale from 1 to 10 (1 corresponding to the best result and 10 the worst). The result will lead to a score of 7 to 70 points

    2. Observer Scar Assessment Scale (OSAS questionnaire) [6 weeks after surgery]

      The OSAS grid is used to evaluate the tolerance and scar quality obtained by the operator. It is based on an evaluation of the healing process thanks to 7 questions whose answers are rated according to an increasing scale from 1 to 10 (1 corresponding to the best result and 10 the worst). The result will lead to a score of 7 to 70 points

    3. Observer Scar Assessment Scale (OSAS questionnaire) [12 weeks after surgery]

      The OSAS grid is used to evaluate the tolerance and scar quality obtained by the operator. It is based on an evaluation of the healing process thanks to 7 questions whose answers are rated according to an increasing scale from 1 to 10 (1 corresponding to the best result and 10 the worst). The result will lead to a score of 7 to 70 points

    4. Revision surgery [6 months after surgery]

    5. Pseudoarthrosis Complication [24 weeks after surgery]

      Presence of delayed healing on radiograph at S24

    6. Visual Analogue Scale (VAS) to evaluate ankle pain [preoperatively]

      The VAS measures the intensity of pain on a scale from 0 to 10 (0= no pain ans 10 = worst pain)

    7. Visual Analogue Scale (VAS) to evaluate ankle pain [24 hours after surgery]

      The VAS measures the intensity of pain on a scale from 0 to 10 (0= no pain ans 10 = worst pain)

    8. Visual Analogue Scale (VAS) to evaluate ankle pain [48 hours after surgery]

      The VAS measures the intensity of pain on a scale from 0 to 10 (0= no pain ans 10 = worst pain)

    9. Visual Analogue Scale (VAS) to evaluate ankle pain [3 weeks after surgery]

      The VAS measures the intensity of pain on a scale from 0 to 10 (0= no pain ans 10 = worst pain)

    10. Visual Analogue Scale (VAS) to evaluate ankle pain [6 weeks after surgery]

      The VAS measures the intensity of pain on a scale from 0 to 10 (0= no pain ans 10 = worst pain)

    11. Visual Analogue Scale (VAS) to evaluate ankle pain [12 weeks after surgery]

      The VAS measures the intensity of pain on a scale from 0 to 10 (0= no pain ans 10 = worst pain)

    12. Visual Analogue Scale (VAS) to evaluate ankle pain [24 weeks after surgery]

      The VAS measures the intensity of pain on a scale from 0 to 10 (0= no pain ans 10 = worst pain)

    13. Transcutaneous oxygen pressure measurements (TcPO2) [before the initiation of oxygen therapy preoperatively]

      The Measurement of TcPO2 will be performed in a subgroup of 40 patients (20 patients in each group)

    14. Transcutaneous oxygen pressure measurements (TcPO2) [48hours after surgery]

      The Measurement of TcPO2 will be performed in a subgroup of 40 patients (20 patients in each group)

    15. Transcutaneous oxygen pressure measurements (TcPO2) [3 weeks after surgery]

      The Measurement of TcPO2 will be performed in a subgroup of 40 patients (20 patients in each group)

    16. EuroQol 5-Dimension (EQ-5D) self-questionnaire [pre-operatively]

      This quality of life questionnaire is completed in order to realize a cost-utility analysis (cost per QALY)

    17. EuroQol 5-Dimension (EQ-5D) self-questionnaire [48 hours after surgery]

      This quality of life questionnaire is completed in order to realize a cost-utility analysis (cost per QALY)

    18. EuroQol 5-Dimension (EQ-5D) self-questionnaire [3 weeks after surgery]

      This quality of life questionnaire is completed in order to realize a cost-utility analysis (cost per QALY)

    19. EuroQol 5-Dimension (EQ-5D) self-questionnaire [6 weeks after surgery]

      This quality of life questionnaire is completed in order to realize a cost-utility analysis (cost per QALY)

    20. EuroQol 5-Dimension (EQ-5D) self-questionnaire [12 weeks after surgery]

      This quality of life questionnaire is completed in order to realize a cost-utility analysis (cost per QALY)

    21. EuroQol 5-Dimension (EQ-5D) self-questionnaire [24 weeks after surgery]

      This quality of life questionnaire is completed in order to realize a cost-utility analysis (cost per QALY)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient over 18 years of age

    • Patient with an ankle joint injury with surgical indication

    • Patient with at least one risk factor for scar complication such as comorbidity(ies) (diabetes, smoking, peripheral neuropathy, obstructive arterial disease of the lower limbs, microangiopathy, treatment influencing healing (chemotherapy, corticosteroids...)) and/or complex fracture

    • Patient affiliated to a social security system

    • Patient having signed an informed consent

    Exclusion Criteria:
    • Patient with chronic respiratory insufficiency

    • Patient with sleep apnea with equipment

    • Patient under long term oxygen therapy

    • Patient with a bilateral ankle fracture

    • Polytrauma patients

    • Pregnant or breastfeeding women or those refusing effective contraception

    • Patient deprived of liberty or under legal protection (guardianship or curatorship)

    • Patient unable to follow the protocol, as judged by the investigator

    • Patient refusing to participate in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dr Gadbed Nantes France 44000

    Sponsors and Collaborators

    • Nantes University Hospital
    • Radiometer Medical ApS

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Nantes University Hospital
    ClinicalTrials.gov Identifier:
    NCT05185115
    Other Study ID Numbers:
    • RC21_0129
    First Posted:
    Jan 11, 2022
    Last Update Posted:
    Jan 11, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 11, 2022